Thrombin/NN
and/CC
thrombin/NN
receptor/NN
agonist/NN
peptide/NN
induce/VBP
early/JJ
events/NNS
of/IN
T/NN
cell/NN
activation/NN
and/CC
synergize/VBP
with/IN
TCR/NN
cross-linking/NN
for/IN
CD69/NN
expression/NN
and/CC
interleukin/NN
2/CD
production/NN
./.

Thrombin/NN
stimulation/NN
of/IN
the/DT
T/NN
leukemic/JJ
cell/NN
line/NN
Jurkat/NN
induced/VBD
a/DT
transient/JJ
increase/NN
in/IN
[Ca2+]i/NN
./.
=====
Proteolytic/JJ
activity/NN
of/IN
the/DT
enzyme/NN
was/VBD
required/VBN
for/IN
this/DT
effect/NN
since/IN
diisopropyl/NN
fluorophosphate-thrombin/NN
failed/VBD
to/TO
increase/VB
[Ca2+]i/NN
./.
=====
Furthermore/RB
,/,
hirudin/NN
and/CC
anti-thrombin/NN
III/CD
inhibited/VBD
the/DT
thrombin-induced/JJ
[Ca2+]i/NN
rise/NN
in/IN
Jurkat/NN
T/NN
cells/NNS
./.
=====
A/DT
synthetic/JJ
thrombin/NN
receptor/NN
agonist/NN
peptide/NN
(/(
TRP/NN
)/)
of/IN
7/CD
residues/NNS
(/(
SFLLRNP/NN
)/)
was/VBD
found/VBN
to/TO
be/VB
as/RB
effective/JJ
as/IN
thrombin/NN
for/IN
[Ca2+]i/NN
mobilization/NN
,/,
and/CC
both/DT
agonists/NNS
induced/VBD
Ca2+/NN
release/NN
exclusively/RB
from/IN
internal/JJ
stores/NNS
./.
=====
Thrombin/NN
stimulated/VBD
tyrosine/NN
phosphorylation/NN
of/IN
several/JJ
proteins/NNS
of/IN
molecular/JJ
mass/NN
40/CD
,/,
42/CD
,/,
70/CD
,/,
120/CD
,/,
and/CC
130/CD
kDa/NN
./.
=====
There/EX
was/VBD
a/DT
good/JJ
correlation/NN
between/IN
thrombin-induced/JJ
tyrosine/NN
phosphorylation/NN
of/IN
the/DT
latter/JJ
three/CD
proteins/NNS
and/CC
Ca2+/NN
mobilization/NN
./.
=====
Thrombin/NN
and/CC
TRP/NN
also/RB
caused/VBD
translocation/NN
of/IN
protein/NN
kinase/NN
C/NN
from/IN
the/DT
cytosol/NN
to/TO
the/DT
plasma/NN
membrane/NN
./.
=====
As/IN
a/DT
likely/JJ
consequence/NN
of/IN
these/DT
events/NNS
,/,
thrombin/NN
activated/VBD
the/DT
nuclear/JJ
factor/NN
NF-kB/NN
./.
=====
Several/JJ
cell/NN
lines/NNS
of/IN
hematopoietic/JJ
origin/NN
including/VBG
the/DT
leukemic/JJ
T/NN
cell/NN
line/NN
HPB.ALL/NN
and/CC
the/DT
erythroleukemic/JJ
cell/NN
line/NN
K562/NN
were/VBD
responsive/JJ
to/TO
thrombin/NN
,/,
whereas/IN
others/NNS
such/JJ
as/IN
THP1/NN
,/,
a/DT
myelomonocytic/JJ
cell/NN
line/NN
,/,
and/CC
BL2/NN
,/,
a/DT
Burkitt/NN
lymphoma/NN
were/VBD
refractory/JJ
to/TO
thrombin/NN
or/CC
TRP/NN
stimulation/NN
./.
=====
The/DT
magnitude/NN
of/IN
the/DT
thrombin/NN
response/NN
in/IN
the/DT
different/JJ
cell/NN
types/NNS
paralleled/VBD
the/DT
expression/NN
of/IN
the/DT
thrombin/NN
receptor/NN
mRNA/NN
./.
=====
We/PRP
found/VBD
that/IN
activation/NN
of/IN
Jurkat/NN
T/NN
cells/NNS
by/IN
a/DT
combination/NN
of/IN
phytohemagglutinin/NN
and/CC
phorbol/NN
12-myristate/NN
13-acetate/NN
led/VBD
to/TO
a/DT
dramatic/JJ
inhibition/NN
of/IN
thrombin/NN
receptor/NN
mRNA/NN
expression/NN
and/CC
to/TO
a/DT
concomitant/JJ
loss/NN
of/IN
the/DT
thrombin/NN
response/NN
./.
=====
Finally/RB
,/,
we/PRP
demonstrate/VBP
that/IN
thrombin/NN
and/CC
TRP/NN
enhanced/VBD
CD69/NN
expression/NN
and/CC
interleukin/NN
2/CD
production/NN
induced/VBN
by/IN
T/NN
cell/NN
receptor/NN
cross-linking/NN
in/IN
both/CC
Jurkat/NN
T/NN
cells/NNS
and/CC
peripheral/JJ
blood/NN
lymphocytes/NNS
./.
=====
These/DT
findings/NNS
highlight/VBP
the/DT
role/NN
of/IN
thrombin/NN
as/IN
a/DT
potential/JJ
regulator/NN
of/IN
T/NN
lymphocyte/NN
activation/NN
./.